SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Culver who wrote (233)10/19/1997 10:18:00 AM
From: F. Jay Abella, III   of 1185
 
Dave:

Any insight on the price correction (on so little volume)?

My take is that the change of ownership from Vancouver retail to CCM (20%)makes the stock less "fun" locally. No? I would love to hear a counterpoint or other rationale as to why NRT would be down to $1.15 - $1.20 after the CCM release, a deal which I think is wildly positive for Nortran.

FJA
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News